COMMUNIQUÉS West-GlobeNewswire

Vystar Contracts Med Air Solutions to White Label ViraTech Air Purification Systems And Distribute to Medical Housing Markets, Nursing Homes and Ecuador
10/06/2019
WORCESTER, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- Vystar® Corp . (OTC: VYST) and Competitive Edge Services LLC DBA Med Air Solutions (MAS) have signed an agreement whereby Med Air Solutions will white label Vystar’s [...]
Canada House Wellness Group Inc. Announces Additions to Senior Management Team
10/06/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 10, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”), a fully [...]
Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac Disease
10/06/2019
Launch of the first ever phase 3 trial in the history of celiac disease RALEIGH, N.C., June 10, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused [...]
HempAmericana Announces Substantial Purchase Order Agreement and New Supplier Relationship with Eagle Hemp
10/06/2019
NEW YORK, June 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is thrilled to announce a new Purchase [...]
Eloxx Pharmaceuticals’ Phase 2 Study of ELX-02 in Cystinosis Receives Authorization of Clinical Trial Application (CTA) by Health Canada and Funding from Genome Quebec and Genome Canada
10/06/2019
Dr. Paul Goodyer, a Professor of Pediatrics at McGill University and recognized leader in hereditary renal disease, will be the principal investigator in the Phase 2 clinical trial Genome Quebec and Genome Canada [...]
CareDx to Participate in Upcoming Conferences
10/06/2019
BRISBANE, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high- [...]
Nexstim Plc: Amendment of stock option programs
10/06/2019
Company announcement, Helsinki, 10 June 2019 at 3.00 PM Nexstim Plc: Amendment of stock option programs Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( "Nexstim" or "Company" ), the targeted neuromodulation company developing and [...]
Shockwave Appoints Hajime Tada as General Counsel
10/06/2019
SANTA CLARA, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
Tabula Rasa HealthCare’s Dr. Sandra Leal is President-elect American Pharmacists Association
10/06/2019
CEO of SinfoníaRx, a TRHC subsidiary, will lead the advancement of the Pharmacy profession as APhA President in 2021 MOORESTOWN, N.J., June 10, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: [...]
GBT Awards More than $200,000 in Grants to Five Nonprofit Organizations through New ACCEL Program Aimed at Improving Access to Healthcare for People Living with Sickle Cell Disease
10/06/2019
Company Created ACCEL (Access to Excellent Care for Sickle Cell Patients Pilot Program) to Accelerate Development of Innovative Healthcare Programs for Sickle Cell Community SOUTH SAN FRANCISCO, Calif., June 10, 2019 ( [...]
Altimmune Announces Successful Pre-IND Meeting with FDA
10/06/2019
Meeting on HepTcell Phase 2 program for treatment of chronic hepatitis B (HBV) GAITHERSBURG, Md., June 10, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today [...]
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
10/06/2019
The new patent expands the robust patent portfolio covering RHB-104 and RHB-204 RedHill plans to initiate a pivotal Phase 3 study with RHB-204 for the treatment of pulmonary nontuberculous mycobacteria (NTM) infections [...]
Oncternal Therapeutics Completes Reverse Merger with GTx, Inc.
10/06/2019
Shares of Oncternal to commence trading on Nasdaq under new ticker symbol ONCT on June 10, 2019 SAN DIEGO, June 10, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., (Nasdaq: ONCT) a clinical-stage biotechnology [...]
IntelGenx Announces Addition of Ottawa Montelukast VersaFilm® Phase 2a Clinical Trial Site; First Patient in Study Completes 26-Week Treatment
10/06/2019
SAINT LAURENT, Quebec, June 10, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), leader in pharmaceutical films, today announced that it has added a new Ottawa site in the Montelukast [...]
Entasis Therapeutics Announces Oral and Poster Presentations of its Pathogen-Targeted Antibiotic Clinical Programs at ASM Microbe 2019
10/06/2019
WALTHAM, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association
10/06/2019
NEWTOWN, Pa., June 10, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial [...]
Artizan Biosciences Announces Corporate Progress and Financing
10/06/2019
Finalized Series A funding, bringing total raised to date to $12MM to support proprietary platform that enables identification of disease-driving bacteria and development of therapies for inflammatory diseases Appointed [...]
T2 Biosystems Reports Granting of Inducement Awards
10/06/2019
LEXINGTON, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Merit Medical to Present at Raymond James Conference
10/06/2019
SOUTH JORDAN, Utah, June 10, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

Pages